FDA Inspection 1334136 — Celltrion Pharm, Inc.

Celltrion Pharm, Inc. — FEI 3012279978

The FDA completed an inspection of Celltrion Pharm, Inc. on Aug 10, 2026 in Cheongju. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Aug 10, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cheongju (Korea (the Republic of))

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.